The Week's Top Stories: Breakthrough COVID, FDA Approvals, and More

This week's most-read stories discussed unforeseen consequences of the COVID-19 pandemic, including an increase in gastrointestinal diseases and a decrease in childhood asthma diagnoses.

Related Videos
Related Content

Unmasking the Truth: How Children Transmitted COVID-19 Within Households

June 5th 2023

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022

Weekly Roundup: The 5 Most Impactful Infectious Disease Stories You Need to Know

June 2nd 2023

Vaccine Race: The Pfizer Vaccine with William Schaffner, MD

November 16th 2020

The Hidden Impact of COVID-19: Deterioration of Mental Health After Hospitalization

June 2nd 2023

A Milestone in RSV Prevention: FDA Approves Pfizer's Abrysvo Vaccine for Older Adults

June 1st 2023

Unmasking the Truth: How Children Transmitted COVID-19 Within Households

June 5th 2023

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022

Weekly Roundup: The 5 Most Impactful Infectious Disease Stories You Need to Know

June 2nd 2023

Vaccine Race: The Pfizer Vaccine with William Schaffner, MD

November 16th 2020

The Hidden Impact of COVID-19: Deterioration of Mental Health After Hospitalization

June 2nd 2023

A Milestone in RSV Prevention: FDA Approves Pfizer's Abrysvo Vaccine for Older Adults

June 1st 2023

Unmasking the Truth: How Children Transmitted COVID-19 Within Households

June 5th 2023

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022

Weekly Roundup: The 5 Most Impactful Infectious Disease Stories You Need to Know

June 2nd 2023

Vaccine Race: The Pfizer Vaccine with William Schaffner, MD

November 16th 2020

The Hidden Impact of COVID-19: Deterioration of Mental Health After Hospitalization

June 2nd 2023

A Milestone in RSV Prevention: FDA Approves Pfizer's Abrysvo Vaccine for Older Adults

June 1st 2023
© 2023 MJH Life Sciences

All rights reserved.